Maxcyte (DI) (MXCT)

 155.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 195.00
  • 52 Week Low: 107.50
  • Currency: UK Pounds
  • Shares Issued: 51.36m
  • Volume: 254,897
  • Market Cap: £79.60m

Maxcyte (DI) Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -50.5% -76.5%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.1 5.3
Pr/Book 8.5  
Latest F'cast
Revenue 19.2% -30.2%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Maxcyte (DI) Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 7.16 (1.84) (1,518.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-15 9.29 (1.45) (186.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-16 12.27 (3.35) (11.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-17 13.98 (9.92) (20.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-18 16.67 (8.87) (17.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Maxcyte (DI) Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 14.92 (11.42) (19.10)p n/a n/a n/a n/a 0.0%
31-Dec-20 19.83 (11.21) (18.64)p n/a n/a n/a n/a 0.0%
31-Dec-21 23.77 (0.39) n/a n/a n/a n/a n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Maxcyte (DI) Company Announcements

Consolidation of Trading Lines 21-Feb-2020 07:00 RNS
AIM Block Admission Return / Total Voting Rights 20-Feb-2020 18:18 RNS
Grant Of Options 24-Jan-2020 16:31 RNS

Maxcyte (DI) ShareCast News

MaxCyte to consolidate stock to single trading l... 21-Feb-2020 ShareCast
MaxCyte 'exceptionally positive' following stron... 20-Jan-2020 ShareCast
MaxCyte inks new development agreement with KSQ ... 04-Dec-2019 ShareCast

Latest Maxcyte (DI) Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Maxcyte (DI) Market Data

Currency UK Pounds
Share Price 155.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 195.00
52 Week Low 107.50
Volume 254,897
Shares Issued 51.36m
Market Cap £79.60m

Maxcyte (DI) Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Maxcyte (DI) Dividends

No dividends found

Trades for 28-Feb-2020

Time Volume / Share Price
16:26 1,000 @ 150.85p
15:07 5,000 @ 159.85p
15:42 2,675 @ 150.85p
13:52 250,000 @ 155.00p
11:38 10,000 @ 151.85p

Maxcyte (DI) Key Personnel

CEO Doug Doerfler
CFO Ron Holtz

Top of Page